Tangdenpaisal, K; Chuayboonsong, K; Ruchirawat, S; Ploypradith, P. Divergent Strategy for the Diastereoselective Synthesis of the Tricyclic 6,7-Diaryltetrahydro-6H-benzo[c]chromene Core via Pt(IV)-Catalyzed Cycloaddition of o-Quinone Methides and Olefin Ring-Closing Metathesis. J. Org. Chem. 2017, 82, 2672−2688.

28 Dec 2017
0
0

Tangdenpaisal, K; Chuayboonsong, K; Ruchirawat, S; Ploypradith, P. Divergent Strategy for the Diastereoselective Synthesis of the Tricyclic 6,7-Diaryltetrahydro-6H-benzo[c]chromene Core via Pt(IV)-Catalyzed Cycloaddition of o-Quinone Methides and Olefin Ring-Closing Metathesis. J. Org. Chem. 2017, 82, 2672−2688.

Tags

Share this

Related Posts

HMP-S7 Is a Novel Anti-Leukemic Peptide Discovered from Human Milk. Chiangjong W, Panachan J, Vanichapol T, Pongsakul N, Pongphitcha P, Siriboonpiputtana T, Lerksuthirat T, Nuntnarumit P, Supapannachart S, Srisomsap C, Svasti J, Hongeng S, Chutipongtanate S*. Biomedicines. 2021 Aug 9;9(8):981.
09 Aug 2021
0

HMP-S7 Is a Novel Anti-Leukemic Peptide Discovered from Human Milk. Chiangjong W, Panachan J, Vanichapol T, Pongsakul N, Pongphitcha P, Siriboonpiputtana T, Lerksuthirat T, Nuntnarumit P, Supapannachart S, Srisomsap C, Svasti J, Hongeng S, Chutipongtanate S*. Biomedicines. 2021 Aug 9;9(8):981.

HMP-S7 Is a Novel Anti-Leukemic Peptide Discovered from Human Milk. Chiangjong W, Panachan J, Vanichapol T, Pongsakul N, Pongphitcha P, Siriboonpiputtana T, Lerksuthirat T, Nuntnarumit P, Supapannachart S, Srisomsap C, Svasti J, Hongeng S, Chutipongtanate S*. Biomedicines. 2021 Aug 9;9(8):981.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More